GB-102

DRUG2 trials

Sponsors

Graybug Vision

Conditions

Diabetic Macular EdemaNeovascular Age-Related Macular DegenerationRetina Vein Occlusion

Phase 1

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

CompletedNCT03249740

Graybug VisionNeovascular Age-Related Macular Degeneration

Start: 2017-08-29End: 2019-01-16Updated: 2019-12-20

Phase 2

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

CompletedNCT04085341

Graybug VisionDiabetic Macular Edema, Retina Vein Occlusion

Start: 2019-09-11End: 2020-06-05Updated: 2021-11-22